Please login to the form below

Not currently logged in
Email:
Password:

Flulaval Quadrivalent

This page shows the latest Flulaval Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

China weighs heavy on GSK figures in Q3

China weighs heavy on GSK figures in Q3

Witty emphasised that GSK is entering a new product launch phase with four approvals since the start of the year - including quadrivalent flu vaccine FluLaval and Tyverb (lapatinib) for use alongside

Latest news

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    FDA approves Flulaval Quadrivalent.  . GlaxoSmithKline has secured US approval for a second four-strain (quadrivalent) influenza vaccine in time for the upcoming flu season. ... The latest approval is for Flulaval Quadrivalent, which has been given the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics